Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $473M (100.0% shares, 0.0% debt)

Holdings (24)

MERUS N V 12.5%
Value $59.22M Shares 2,615,762 Est. Cost $25.66 Unrealized
XENE XENON PHARMACEUTICALS INC 10.3%
Value $48.52M Shares 1,594,932 Est. Cost $24.38 Unrealized +24.1%
COGT COGENT BIOSCIENCES INC 9.4%
Value $44.6M Shares 4,944,708 Est. Cost $8.05 Unrealized -15.2%
BELLUS HEALTH INC NEW 8.8%
Value $41.39M Shares 4,479,784 Est. Cost $7.53 Unrealized
CYTK CYTOKINETICS INC 7.4%
Value $35.11M Shares 893,646 Est. Cost $26.78 Unrealized +50.3%
ACRS ACLARIS THERAPEUTICS INC 7.1%
Value $33.65M Shares 2,410,622 Est. Cost $12.97 Unrealized +8.0%
KURA KURA ONCOLOGY INC 7.1%
Value $33.48M Shares 1,826,491 Est. Cost $14.41 Unrealized -0.2%
IVERIC BIO INC 4.9%
Value $23.18M Shares 2,409,961 Est. Cost $11.01 Unrealized
TRICIDA INC 4.2%
Value $19.64M Shares 2,028,453 Est. Cost $9.25 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 4.0%
Value $18.96M Shares 1,638,609 Est. Cost $15.34 Unrealized -12.4%
CYMABAY THERAPEUTICS INC 3.6%
Value $16.93M Shares 5,738,500 Est. Cost $4.40 Unrealized
SATSUMA PHARMACEUTICALS INC 3.2%
Value $15.37M Shares 3,711,286 Est. Cost $5.89 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 3.1%
Value $14.53M Shares 538,812 Est. Cost $30.35 Unrealized -4.3%
DAWN DAY ONE BIOPHARMACEUTICALS I 2.8%
Value $13.24M Shares 739,661 Est. Cost $10.33 Unrealized 0.0%
VISTAGEN THERAPEUTICS INC 2.4%
Value $11.48M Shares 13,049,079 Est. Cost $1.73 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 2.3%
Value $11M Shares 312,533 Est. Cost $37.62 Unrealized 0.0%
KARYOPHARM THERAPEUTICS INC 1.8%
Value $8.73M Shares 1,935,609 Est. Cost $7.37 Unrealized
CELC CELCUITY INC 1.8%
Value $8.376M Shares 920,464 Est. Cost $25.49 Unrealized -71.3%
RZLT REZOLUTE INC 0.8%
Value $3.908M Shares 1,210,000 Est. Cost $3.32 Unrealized 0.0%
IMUX IMMUNIC INC 0.7%
Value $3.099M Shares 893,013 Est. Cost $11.58 Unrealized -44.6%
KALV KALVISTA PHARMACEUTICALS INC 0.7%
Value $3.076M Shares 312,553 Est. Cost $24.62 Unrealized -55.2%
BCLS ACQUISITION CORP 0.5%
Value $2.475M Shares 250,000 Est. Cost $11.14 Unrealized
TNYA TENAYA THERAPEUTICS INC 0.4%
Value $2.014M Shares 357,699 Est. Cost $21.49 Unrealized -62.3%
IVA INVENTIVA SA 0.2%
Value $995K Shares 175,500 Est. Cost $14.53 Unrealized